Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epithelial-Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly.

Frontiers in endocrinology - 1 Jan 2021

Gil Joan, Jordà Mireia, Soldevila Berta, Puig-Domingo Manel

Abstract excerpt

Epithelial-mesenchymal transition (EMT) is a dynamic process by which epithelial cells loss their phenotype and acquire mesenchymal traits, including increased migratory and invasive capacities. EMT is involved in physiological processes, such as embryogenesis and wound healing, and in pathological processes such as cancer, playing a pivotal role in tumor progression and metastasis. Pituitary tumors, although...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acromegaly
Share to Cadherins
Share to Cytoskeleton

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endocrine Gland Neoplasms

Share to Epithelial-Mesenchymal Transition

Share to Pituitary Neoplasms

Share to Receptors, Somatostatin

Share to Somatostatin

Source

Open in PubMed Open full text

Identifiers

PMID: 33790868
DOI: 10.3389/fendo.2021.646210
PMCID: PMC8006574

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epithelial-Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly.PMID 33790868Read ↗

Gene Expression Profiling Identifies ESRP1 as a Potential Regulator of Epithelial Mesenchymal Transition in Somatotroph Adenomas from a Large Cohort of Patients with AcromegalySemantic proximity Read ↗

miR-383-5p, miR-181a-5p, and miR-181b-5p as Predictors of Response to First-Generation Somatostatin Receptor Ligands in AcromegalySemantic proximity Read ↗

Co-secretion of growth hormone and prolactin defines a high-risk acromegaly phenotype.Semantic proximity Read ↗

Human Somatostatin Receptor Subtypes in Acromegaly: Distinct Patterns of Messenger Ribonucleic Acid Expression and Hormone Suppression Identify Different Tumoral PhenotypesSemantic proximity Read ↗

Co-secretion of growth hormone and prolactin defines a high-risk acromegaly phenotypeSemantic proximity Read ↗

Treatment of acromegaly in the era of personalized and predictive medicine.Semantic proximity Read ↗

Integrative proteomics and transcriptomics revealed that activation of the IL-6R/JAK2/STAT3/MMP9 signaling pathway is correlated with invasion of pituitary null cell adenomasSemantic proximity Read ↗

Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumorsSemantic proximity Read ↗

Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton InvolvementSemantic proximity Read ↗

Pituitary tumour fibroblast-derived cytokines influence tumour aggressivenessSemantic proximity Read ↗

Molecular Characterization of Growth Hormone-producing Tumors in the GC Rat Model of Acromegaly.Semantic proximity Read ↗

Differential expression of microRNAs in GH-secreting pituitary adenomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.